Intrinsiqq
Annexon, Inc. logo

Annexon, Inc. Financials

ANNX

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 7 available years
Income Statement
DEC 2025
DEC 2024
~1.8:1 split
DEC 2023
~1.4:1 split
DEC 2022
~1.4:1 split
DEC 2021
~2.3:1 split
General & Administrative$32$35$30$33$31
Research & Development$185$119$114$113$100
Total Operating Expenses$216$154$144$146$131
Operating Income-$216-$154-$144-$146-$131
EBT (Earnings Before Tax)-$207-$138$134$142$130
Income Tax Expense$0$0$0$0–
Net Income
Net Income-$207-$138-$134-$142-$130
EPS (Basic)-$1.34-$1.01-$1.77-$2.60-$3.40
EPS (Diluted)-$1.34-$1.01-$1.77-$2.60-$3.40
Weighted Avg Shares (Basic)155.1M137.4M75.7M54.7M38.3M
Weighted Avg Shares (Diluted)155.1M137.4M75.7M54.7M38.3M
Shares Outstanding155.1M137.4M75.7M54.7M38.3M
Dividends Per Share$0.00$0.00$0.00$0.00$0.00

Annexon (ANNX) financials: revenue, profit and margins

Annexon (ANNX) generated about n/a in revenue and -$199 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Annexon profitable?+

Annexon reported about -$199 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 9 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 10 Nov 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ANNX

CompareIntrinsic value
SVRASavara Inc.
$4.26-18.23%10
CYRXCryoport Inc.
$19.05-2.56%13
MRVIMaravai Lifesciences Holdings Inc.
$6.98-2.92%10
AMPHAmphastar Pharmaceuticals Inc.
$28.25+0.50%64
MNKDMannKind Corporation
$3.85-2.53%30
COYACoya Therapeutics Inc.
$2.95-1.01%10
ATOSAtossa Therapeutics Inc
$1.60-8.86%10
XLOXilio Therapeutics, Inc.
$7.56+0.67%50

Held by ETFs

ANNX is in 28 US ETFs. The largest of them, with ANNX's weight in each:

Spot a number that looks wrong? Check it in ANNX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ANNX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.